SOPHiA Genetics SA

SOPHiA Genetics SA

SOPH

Get informed when a big investor buys or sells

+ Follow
Market Cap$625.69M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
SOPHiA Genetics SASOPHiA Genetics SA-6.4--97%7.50.9
$11.67

Target Price by Analysts

55.1% upsideSOPHiA Genetics SA Target Price DetailsTarget Price

Share Statistics

Market cap$625.69 Million
Enterprise Value$595.47 Million
Dividend Yield$- (-)
Earnings per Share$-1.17
Beta0.95
Outstanding Shares73,838,486

Return

Return on Equity-97.31%ROE
Return on Assets-40.77%
Return on Invested Capital-50.15%

Valuation & Multiples

P/E Ratio-6.39P/E Ratio
PEG2469.91PEG
Price to Sales7.52Price to Sales
Price to Book Ratio7.52Price to Book Ratio
Enterprise Value to Revenue6.91
Enterprise Value to EBIT-8.06
Enterprise Value to Net Income-8
Total Debt to Enterprise0.13
Debt to Equity0.93Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 11, 2026
EPS Estimate
$-0.22
Average shareholder expectation
Revenue Estimate
$21.85 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 3, 2026
EPS Estimate
$-0.20
Average shareholder expectation
Revenue Estimate
$24.03 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-▼ 100.00%
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.46%▼ 49.43%
Total Invested$2.87M▼ 98.65%
Investors Holding1▼ 74.00%

ESG Score

No data

About SOPHiA Genetics SA

SOPHiA Genetics SA Insider Information FAQ

Stockcircle tracks 6 top investors with a current 13F position in SOPHiA Genetics SA. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 3 top investors increased or opened positions among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 1 open-market insider purchase and 77 open-market insider sales for SOPHiA Genetics SA in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.